Tissue-resident memory-like T cells in tumor immunity: Clinical implications

Semin Immunol. 2020 Jun:49:101415. doi: 10.1016/j.smim.2020.101415. Epub 2020 Sep 30.

Abstract

Tissue-resident memory (TRM) T cells are distinct population of non-circulating lymphocytes that play an important role in mediating regional immunity. TRM- like cells have now been identified as a component of tumor-infiltrating lymphocytes in several human tumors and correlate with outcome and response to immunotherapy. TRM cells have also been shown to mediate anti-tumor immunity in murine models. Biology of TRM cells has several implications for clinical cancer immunotherapy. Here we discuss newer insights into the biology of TRM T cells and discuss their implications for understanding the heterogeneity of immune microenvironment in tumors as well as improving the efficacy of cancer vaccines, immune-checkpoint blockade and adoptive cellular therapies in the clinic.

Keywords: Tissue resident memory; Tumor immunity; Tumor infiltrating lymphocytes.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Cancer Vaccines / immunology
  • Combined Modality Therapy
  • Humans
  • Immune Checkpoint Inhibitors / pharmacology
  • Immune Checkpoint Inhibitors / therapeutic use
  • Immunologic Memory*
  • Immunotherapy, Adoptive
  • Lymphocytes, Tumor-Infiltrating / immunology*
  • Lymphocytes, Tumor-Infiltrating / metabolism*
  • Neoplasms / immunology*
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Neoplasms / therapy
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism*
  • Tumor Microenvironment / immunology

Substances

  • Cancer Vaccines
  • Immune Checkpoint Inhibitors